G&L Scientific

G&L Scientific (also known as G&L Healthcare Advisors) is a premier global consultancy specializing in Regulatory Affairs and Quality Assurance for the pharmaceutical, biotechnology, and medical device industries. Founded in 2016, the company provides a comprehensive suite of services including global regulatory strategy, clinical development support, CMC (Chemistry, Manufacturing, and Controls), and market access solutions. G&L operates as an 'Integrated Product Development and Market Access Platform,' helping clients navigate the entire product lifecycle from discovery to commercialization. The company has expanded rapidly through a combination of organic growth and aggressive strategic acquisitions. It serves a diverse client base ranging from small incubator startups to some of the world's largest pharmaceutical firms. G&L is recognized for its 'Functional Service Provider' (FSP) and 'Staff Augmentation' models, which allow life sciences companies to scale their regulatory and quality functions efficiently. In 2024, the company underwent a significant ownership change when the investment firm Armira acquired a majority stake to fuel further international expansion.